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was slightly lower, but still acceptable, for the assessment of synovial
effusion, cartilage abnormalities, ligaments abnormalities and meniscus
ﬁssure grade. A correlation was observed between pain VAS score at
baseline and the subchondral oedema (r = 0.24).
After 48 weeks, an improvement of symptomatology was observed in
both treatment groups without signiﬁcant difference between groups.
An increase in total cartilage volume was observed in the Structum®
group (+180mm3 +SD) whereas a loss was revealed in the placebo
(−46mm3 +SD). However, due to the very high variability of measure-
ments, no signiﬁcant treatment effect could be shown.
No statitistically signiﬁcant differences between groups were observed
for subchondral oedema, osteophytes, subchondral cysts, meniscus ﬁs-
sure grade, cartilage abnormalities, synovitis or synovial effusion. No
correlations were evidenced between key MRI parameters changes after
48 weeks and clinical symptomatology.
Conclusions: Despite the weak correlation between clinical symptoms
and MRI, the observed difference in the evolution of cartilage volume be-
tween the 2 groups could reﬂect a structure modifying effect of Structum®.
Hence, a larger and longer longitudinal study will be needed to conﬁrm
MRI ﬁndings.
This pilot study conﬁrm the usefulness of quantitative and qualitative MRI
as a sensitive tool to assess a structure modifying drugs in KOA.
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Purpose: The major risk factors for osteoarthritis (OA) are known, allow-
ing to identify high-risk groups. Several biochemical markers and imaging
techniques are available that may identify early signs of OA. Because of
the chronic progressive character of OA and severe disability and pain
to which it can lead, early treatment in a pre-clinical stage should be
explored. This can be achieved if we can easily identify: (a) people in pre-
clinical stage of OA, (b) people at extreme high risk, and (c) determinants
for a deterioration into a clinically manifest OA.
Therefore, the present study has two major aims: (1) to identify early
predictive signs of clinically manifest OA of the knee in predeﬁned high-
risk groups, and (2) to identify extremely high-risk groups to develop knee
OA, by establishing what additional factors determine a clinically manifest
OA in a pre-deﬁned high-risk group.
Methods: A nested prospective cohort of 800 women aged 45−60 years
will be studied. These women were part of the participants who were
invited from 2006 onwards to extend the Rotterdam Study. We included
the following high-risk groups: middle-aged females without OA, but
with known risk factors for knee OA like overweight (400 women),
malalignment (100 women), and history of knee trauma (100 women).
Furthermore, we include a group with unilateral knee OA (100 women),
and 100 female controls (without OA and risk factors).
At baseline all participants of the Rotterdam Study had x-rays and whole-
body dexa scans, blood and urine was collected and a questionnaire was
administered.
Participants are identiﬁed based on data from baseline measurement
of the Rotterdam study and their knee x-rays, which are scored for OA
with Kellgren and Lawrence classiﬁcation system. After identiﬁcation of
women at high risk a telephonic screening for pain and contraindications
for MRI is done. If eligible, they are asked to visit the research centre for
an additional questionnaire and a MRI scan and physical examination of
both knees. MRI will be scored for OA with Knee Osteoarthritis Scoring
System (KOSS), and shape modelling based on x-rays will be done as
well as quantitative scoring of cartilage on MRI. Physical examination
contains the SQUASH and KOOS among other things. Every 1.5 year a
questionnaire will be send to the participants and ﬁrst follow-up will be
after 3 years, with in principal unlimited follow up every 3 years.
Results: We started in august 2007, and included 344 women so far, of
which 205 in the overweight group, 98 in the group with malalignment,
25 in the group with unilateral knee OA, 15 in the history of trauma group
and invited 46 controls. The only high-risk group in which women can
have pain is the high-risk group with unilateral knee OA. We aim to fulﬁll
the inclusion in April 2009.
Conclusions: Our cohort is more or less comparable with the Incidence
subcohort of the Osteoarthritis Initiative (OAI). A difference is that all
our participants in high-risk groups will not have knee pain, except the
unilateral knee OA group. All participants in the Incidence subcohort of
OAI in age category of 45−49 will have knee pain and all in age-category
50−69 can have knee pain. Furthermore, we have another risk group
with malalignment in our study. Therefore, our study can give important
information in addition to the OAI Incidence subcohort as well as essential
replication data.
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Purpose: The cause of primary osteoarthritis/osteoarthrosis (OA) has a
mechanical background. Excessive joint loading is suspected to initiate
a sequence of events that may eventually lead to joint degradation. One
of these events is the thickening and stiffening of the subchondral bone
(SCB). SCB and the overlying articular cartilage perform as a functional
unit. Presently, little is known about the mechanical interaction between
cartilage and bone in the etiology of OA.
OA is one of the most common arthritis forms affecting the temporo-
mandibular joint (TMJ). Micro-computed tomography (mCT) can be used
to detect OA-related bone abnormalities like erosion and osteophytosis
of the TMJ components (i.e., condyle, fossa, and tubercle) and to assess
the complete bone structure. The articular cartilage covering the condyle,
fossa and tubercle, as well as the cartilaginous articular disc, may also be
affected by OA-associated degenerative changes. It is difﬁcult to visualize
these structures directly with mCT. However, assessment of cartilage can
be facilitated by applying a hydrophilic contrast agent. The aim of this
study was to test the application of a highly hydrophilic, tri-iodinated
contrast medium (Optiray) for in vitro assessment of bone and cartilage
components with mCT in the human TMJ.
Methods: Three human TMJ samples (1 healthy, 2 OA-classiﬁed) were
treated with contrast medium Optiray (Tyco Healthcare Nederland BV,
the Netherlands) to enhance cartilage contrast. The samples were sub-
merged for two hours in Optiray (51% ioversol). Before and after this
treatment, the samples were scanned and evaluated with a mCT system
(mCT 40, Scanco medical AG, Switzerland, resolution: 18 mm). During
scanning, the samples were submerged in a hydrophobic ﬂuid to prevent
diffusion of Optiray out of the soft tissues. From the images, the thickness
of the cartilage layers was determined in three regions (i.e., medial,
midsagittal, and lateral). Furthermore, the images were segmented and
3D reconstructions could be made to visualize bone and cartilage tissue
separately.
Figure 1 (a) Midsagittal cross-section of a healthy TMJ after Optiray
treatment. (b) Enlargement of articular cartilage (AC). (c) Superior view
of OA-classiﬁed condyle and (d) overlying articular cartilage.
